Since you have loaded the slide deck, you now know this is no longer a pain company; it is misleading to post anything about painkillers and this company going forward. This company thinks it has something big for Alzheimer's, both treatment and detection. A conf call question indicated the last raise was at $1.15 for a share and some fraction of restricted warrant.
I am impressed by the knowledge demonstrated by traders, including here, and cheer for your successes, like yesterday. This seems like it will be a company for high risk investment, less likely a short term trade. Cheers!